Probiotics for mild Alzheimer's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether daily probiotics (beneficial bacteria) can help people with mild Alzheimer's disease. It's an early-phase trial to see if probiotics are safe and might improve thinking and memory.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older
- You have been diagnosed with mild Alzheimer's disease (MMSE score 19-23)
- You have not taken antibiotics in the last 6 months
- You have not taken probiotics in the last 6 months
- You do not have other serious health conditions (like neurological disease, major depression, gastrointestinal disease, or heart disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This study tests whether taking a specific probiotic (a beneficial bacteria) can help improve memory and thinking in people with mild cognitive impairment who show signs of amyloid in the brain. If you qualify, you'll be randomly assigned to receive either the probiotic or a placebo (a dummy pill) to see if it helps.
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
This study tests whether a daily supplement containing special bacteria and fiber from agave (a type of prebiotic) can improve memory and thinking in older adults with mild cognitive impairment. It looks at the connection between the gut and the brain.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.